Systemic autoimmune diseases (SADs) are a significant cause of morbidity and mortality
worldwide, although their epidemiological profile varies significantly country by country. We …

Previous studies of stroke in systemic lupus erythematosus (SLE) have had limited statistical
power, combined stroke subtypes into composite outcomes, and lacked a reference …

Glucocorticoids are often required for adequate control of inflammation in many serious
inflammatory diseases; common indications for long-term treatment include polymyalgia …

Objectives To review the evidence for accuracy of imaging for diagnosis of polymyalgia
rheumatica (PMR). Methods Searches included MEDLINE, EMBASE and PubMed …

Background and aim Comorbidities are known to exist in many rheumatological conditions.
Polymyalgia rheumatica (PMR) is a common inflammatory rheumatological condition …

Objectives Evidence of the association of polymyalgia rheumatica (PMR) and giant cell
arteritis (GCA) with the full range of cardiovascular diseases (CVDs) is limited. We examined …

Polymyalgia rheumatica (PMR) occurs almost exclusively in persons aged 50 years or older
and it is the second most common inflammatory rheumatic disease in older people after …

Objective To investigate the use of glucocorticoids (GC s) and related adverse events (AE s)
in a long‐term, geographically defined cohort of patients with polymyalgia rheumatica …

Objectives Polymyalgia rheumatica (PMR) is a systemic inflammatory disease in the elderly
of unknown etiology. While glucocorticoids are the mainstay of treatment for PMR, various …

Abstract Purpose of the Review Polymyalgia rheumatica (PMR) is one of the most common
inflammatory rheumatologic condition occurring in older adults. It is characterized by …